Your browser doesn't support javascript.
loading
SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.
Mari, Yelenis; West, Graham M; Scharager-Tapia, Catherina; Pascal, Bruce D; Garcia-Ordonez, Ruben D; Griffin, Patrick R.
Afiliación
  • Mari Y; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
  • West GM; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
  • Scharager-Tapia C; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
  • Pascal BD; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
  • Garcia-Ordonez RD; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
  • Griffin PR; Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
J Proteome Res ; 14(11): 4571-80, 2015 Nov 06.
Article en En | MEDLINE | ID: mdl-26398198
ABSTRACT
Liver receptor homologue-1 (LRH1) is an orphan nuclear receptor that has been shown to play a role in the transcriptional regulation of pathways involved in cancer. Elucidating the components of the LRH1 transcriptional complex to better understand endogenous regulation of the receptor as well as its role in cancer remains a high priority. A sub-cellular enrichment strategy coupled with proteomic approaches was employed to identify putative LRH1 co-regulators. Nuclear fractionation protocol was essential for detection of LRH1 peptides by mass spectrometry (MS), with most peptides being observed in the insoluble fraction (receptor bound to DNA). SERBP1 and ILF3 were identified as LRH1 interacting partners by both Western blot and MS/MS analysis. Receptor knockdown by siRNA showed an increase in SERBP1 expression, while ILF3 expression was unchanged. In contrast, receptor overexpression decreased only SERBP1 mRNA levels. Consistent with these data, in a promoterreporter assay, binding of LRH1 to the promoter region of SERBP1 resulted in a decrease in the expression level of the reporter gene, subsequently inhibiting transcription. Given the receptor's role in cancer progression, the study here elucidates additional transcriptional machinery involved in LRH1 signaling and potentially provides new targets for therapeutics development.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Transcripción Genética / Regulación de la Expresión Génica / Proteínas de Unión al ARN / Receptores Citoplasmáticos y Nucleares Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Transcripción Genética / Regulación de la Expresión Génica / Proteínas de Unión al ARN / Receptores Citoplasmáticos y Nucleares Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos